XETRA - Delayed Quote EUR
Johnson & Johnson (JNJ.DE)
136.32
-0.22
(-0.16%)
At close: April 24 at 5:35:35 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.35M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DUATO JOAQUIN BOIX Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 18, 2025 |
| DECKER ROBERT J Officer | Sale at price 165.88 per share. | Direct | 1,160,994 | Feb 25, 2025 |
| DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 101.87 per share. | Direct | 712,988 | Feb 25, 2025 |
| SCHMID TIMOTHY Officer | Sale at price 156.15 per share. | Direct | 62,928 | Feb 18, 2025 |
| WENGEL KATHRYN E Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
| DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
| WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 14, 2025 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 14, 2025 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 14, 2025 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
| FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 14, 2025 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
| MULHOLLAND KRISTEN Officer | -- | Direct | -- | Feb 14, 2025 |
| REED JOHN C Officer | -- | Direct | -- | Feb 14, 2025 |
| WOLK JOSEPH J Chief Financial Officer | Sale at price 153.89 per share. | Direct | 2,002,878 | Feb 7, 2025 |
| WENGEL KATHRYN E Chief Operating Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 3,278,166 | Feb 7, 2025 |
| DUATO JOAQUIN BOIX Chief Executive Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 12,644,482 | Feb 7, 2025 |
| WOLK JOSEPH J Chief Financial Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 1,302,281 | Feb 7, 2025 |
| TAUBERT JENNIFER L Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 5,853,910 | Feb 7, 2025 |
| WEINBERGER MARK A Director | Purchase at price 147.22 per share. | Direct | 147,220 | Dec 12, 2024 |
| WOLK JOSEPH J Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 17, 2024 |
| DECKER ROBERT J Officer | Sale at price 165.06 per share. | Direct | 930,113 | Aug 30, 2024 |
| DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 563,838 | Aug 30, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Jul 8, 2024 |
| REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
| REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
| WOODS EUGENE A Director | Purchase at price 145.53 per share. | Indirect | 14,553 | Apr 30, 2024 |
| BROADHURST VANESSA Officer | Sale at price 162.16 per share. | Direct | 1,441,765 | Mar 13, 2024 |
| WENGEL KATHRYN E Officer | -- | Direct | -- | Feb 13, 2024 |
| DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 13, 2024 |
| WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 13, 2024 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 13, 2024 |
| HAIT WILLIAM Officer | -- | Direct | -- | Feb 13, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 13, 2024 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 13, 2024 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 13, 2024 |
| FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 13, 2024 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 13, 2024 |
| FASOLO PETER M Officer | -- | Direct | -- | Feb 13, 2024 |
| BROADHURST VANESSA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| WENGEL KATHRYN E Chief Technology Officer | -- | Direct | -- | Feb 12, 2024 |
| DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 12, 2024 |
| WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 12, 2024 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 12, 2024 |
| HAIT WILLIAM Officer | -- | Direct | -- | Feb 12, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 12, 2024 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 12, 2024 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 12, 2024 |
Related Tickers
ZEG.DE AstraZeneca PLC
122.30
+1.03%
PFE.CL Pfizer Inc.
97,340.00
+1.08%
PFE.DE Pfizer Inc.
20.04
+1.78%
C43.DE Cosmo Pharmaceuticals N.V.
50.00
0.00%
GIS.DE Gilead Sciences, Inc.
94.56
+1.74%
IDP.DE Biogen Inc.
105.50
+1.49%
ZEG.SG AstraZeneca PLC
121.55
+0.45%
IDP.HM Biogen Inc
105.20
+0.91%
SNW.DE Sanofi
93.33
-0.07%
BRM.DE Bristol-Myers Squibb Company
42.60
+0.73%